Trial Profile
Evaluating the Effects of Varenicline on Smoking Lapse in Smokers With and Without Schizophrenia: Implications for Treatment
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Feb 2017
Price :
$35
*
At a glance
- Drugs Varenicline (Primary)
- Indications Smoking withdrawal
- Focus Therapeutic Use
- 10 Jul 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 14 May 2015 New trial record